Search Results | Blood | American Society of Hematology

1-20 of 31

Sort by

Sort Order Select

Journal Articles

Early intestinal microbial features are associated with CD4 T-cell recovery after allogeneic hematopoietic transplant

Blood (2022) 139 (18): 2758–2769.

DOI: https://doi.org/10.1182/blood.2021014255

Published: 2022

Includes: Supplemental data

Journal Articles

TP53 and CD19-Directed Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in Large B-Cell Lymphoma

Blood (2021) 138 (Supplement 1): 710.

DOI: https://doi.org/10.1182/blood-2021-145158

Published: 2021

Journal Articles

Five-Year Experience Using Bridging Radiotherapy Prior to Chimeric Antigen Receptor (CAR) T-Cell Therapies for B-Cell Malignancies at Memorial Sloan Kettering Cancer Center

Blood (2021) 138 (Supplement 1): 2507.

DOI: https://doi.org/10.1182/blood-2021-151179

Published: 2021

Journal Articles

KIR-HLA Interactions Lack Clinical Utility in Matched Unrelated Donor Transplantation for AML: An Analysis of the CIBMTR and DRST Registries

Joshua A Fein, Roni Shouval, Elizabeth Krieger, Henning Baldauf, Katharina Fleischhauer, Nicolaus Kroeger, Mary M. Horowitz, Martin Maiers, Karl-Johan Malmberg, Jeffrey S. Miller, Mohamad Mohty, Arnon Nagler, Rizwan Romee, Johannes Schetelig, Stephen R. Spellman, Amir Ahmed Toor, Tao Wang, Daniel J. Weisdorf, John Koreth

Blood (2021) 138 (Supplement 1): 419.

DOI: https://doi.org/10.1182/blood-2021-149935

Published: 2021

Journal Articles

Lesion Characteristics and Patterns of Failure in Diffuse Large B Cell Lymphoma Patients Treated with Bridging Radiotherapy Prior to Chimeric Antigen Receptor T Cell Therapy

Blood (2021) 138 (Supplement 1): 1429.

DOI: https://doi.org/10.1182/blood-2021-149702

Published: 2021

Journal Articles

Novel Agents May be Preferable to Chemotherapy for Large B-Cell Lymphoma Progressing after CD19-CAR-T: A Multicenter Observational Study

Blood (2021) 138 (Supplement 1): 883.

DOI: https://doi.org/10.1182/blood-2021-147568

Published: 2021

Journal Articles

Encouraging Survival and High Rates of Toxicity: Allogeneic Hematopoietic Cell Transplantation after Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy in Aggressive Lymphoma Patients

Shalev Fried, Ivetta Danylesko, Ronit Yerushalmi, Noga Shem-Tov, Roni Shouval, Joshua A Fein, Zachary Cohen, Elad Jacoby, Michal Besser, Arnon Nagler, Avichai Shimoni, Abraham Avigdor

Blood (2021) 138 (Supplement 1): 910.

DOI: https://doi.org/10.1182/blood-2021-147148

Published: 2021

Journal Articles

Primum non nocere: allo-HSCT for AML in CR1

Roni Shouval, Robert J. Soiffer

Blood (2021) 137 (4): 438–439.

DOI: https://doi.org/10.1182/blood.2020008641

Published: 2021

Journal Articles

Personalized Risk-Profiling for Acute Leukemia Patients Undergoing Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation: A Study on Behalf of the Acute Leukemia Working Party of the EBMT

Joshua A Fein, MD, Roni Shouval, MD PhD, Myriam Labopin, MD, Fabio Ciceri, MD, Emanuele Angelucci, MD, Didier Blaise, MD, Johanna Tischer, William Arcese, MD PhD, Yener Koc, MD, Benedetto Bruno, MD, Jose L. Diez-Martin, MD PhD, Stella Santarone, MD, Simona Sica, MD PhD, Jurjen Versluis, Mohamad Mohty, MD PhD, Arnon Nagler, MD

Blood (2020) 136 (Supplement 1): 24–25.

DOI: https://doi.org/10.1182/blood-2020-139519

Published: 2020

Journal Articles

The Disease-Risk Stratification Scheme (DRSS), a Contemporary Risk-Stratification System for Allogeneic Stem Cell Transplantation

Blood (2019) 134 (Supplement_1): 43.

DOI: https://doi.org/10.1182/blood-2019-123310

Published: 2019

Journal Articles

Easix and Modified-Easix Are Early Predictors of Severe Cytokine Release Syndrome and Neurotoxicity in Patients Treated with Chimeric Antigen Receptor T Cells

Blood (2019) 134 (Supplement_1): 1947.

DOI: https://doi.org/10.1182/blood-2019-126208

Published: 2019

Journal Articles

Comparing Gradings of Immune Effector Cells Toxicities: Application of Astct Consensus Grading System and Implications for Clinical Management

Blood (2019) 134 (Supplement_1): 4458.

DOI: https://doi.org/10.1182/blood-2019-126022

Published: 2019

Journal Articles

Early Organ Toxicity Following Allogeneic Hematopoietic Stem Cell Transplantation Differs By Conditioning Regimen

Joshua A Fein, MD, Avichai Shimoni, MD, Ivetta Danylesko, Noga Shem-Tov, MD, Ronit Yerushalmi, MD, Guy Chowers, MD, Zachary Cohen, Arnon Nagler, MD MSc, Roni Shouval

Blood (2019) 134 (Supplement_1): 4489.

DOI: https://doi.org/10.1182/blood-2019-126325

Published: 2019

Journal Articles

Lactate Dehydrogenase Is a Key Prognostic Factor in Acute Myeloid Leukemia and Lymphoma Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Mika Geva, Roni Shouval, Joshua A Fein, MD, Ivetta Danylesko, Noga Shem-Tov, MD, Ronit Yerushalmi, MD, Avichai Shimoni, MD, Arnon Nagler, MD MSc

Blood (2019) 134 (Supplement_1): 3304.

DOI: https://doi.org/10.1182/blood-2019-125529

Published: 2019

Journal Articles

Oral Mucositis Is Associated with Distinctive Patterns of Oral Microbiota Injury in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Roni Shouval, Adi Eshel, MSc, Ivetta Danylesko, Bar Dubovski, Joshua A Fein, MD, Shalev Fried, Mika Geva, MD, Elizaveta Kouniavsky, Amir A Kuperman, MD MSc, Yoram Louzoun, PhD, Omry Koren, PhD, Arnon Nagler, MD MSc

Blood (2019) 134 (Supplement_1): 3265.

DOI: https://doi.org/10.1182/blood-2019-125433

Published: 2019

Journal Articles

Comorbidity-Associated Risk of Overall Mortality Following Hematopoietic Stem-Cell Transplantation Is Regimen-Dependent: A Study from the Acute Leukemia Working Party of the EBMT

Joshua Fein, Myriam Labopin, MD, Roni Shouval, MD PhD, Gerard Socie, MD PhD, Jürgen Finke, MD, Jan J Cornelissen, MD PhD, Ram Malladi, Maija Itälä-Remes, MD PhD, Patrice Chevallier, MD, Kim H. Orchard, MBBS,PhDFRCP,FRCPath, Donald Bunjes, MD, Mahmoud Aljurf, MD, Marie Thérèse Rubio, MD, Mohamad Mohty, MD PhD, Arnon Nagler, MD

Blood (2018) 132 (Supplement 1): 203.

DOI: https://doi.org/10.1182/blood-2018-99-113296

Published: 2018

Journal Articles

Repeated Courses of Orally Administered Fecal Microbiota Transplantation for the Treatment of Steroid Resistant and Steroid Dependent Intestinal Acute Graft Vs. Host Disease: A Pilot Study (NCT 03214289)

Roni Shouval, MD PhD, Ilan Youngster, MD MSc, Mika Geva, MD, Adi Eshel, MSc, Ivetta Danylesko, MD, Avichai Shimoni, MD, Katia Beider, Joshua A Fein, Itai Sharon, PhD, Omry Koren, PhD, Arnon Nagler, MD

Blood (2018) 132 (Supplement 1): 2121.

DOI: https://doi.org/10.1182/blood-2018-99-110270

Published: 2018

Journal Articles

FLT3 and NPM1 Are Powerful Determinants of Outcome in Acute Myeloid Leukemia Patients Treated with Autologous Stem Cell Transplantation: An Analysis By the Acute Leukemia Working Party of the EBMT

Roni Shouval, MD PhD, Myriam Labopin, MD, David Bomze, MSc, Gabriela M Baerlocher, Robin Foà, MD, Didier Blaise, Mathias Haenel, MD, Edouard Forcade, MD, Anne Huynh, MD, Riccardo Saccardi, MD, Giuseppe Milone, MDPhD, Tsila Zuckerman, MD, Péter Reményi, MD, Jordi Esteve, MD PhD, Norbert Claude Gorin, MDPhD, Mohamad Mohty, MD PhD, Arnon Nagler, MD

Blood (2018) 132 (Supplement 1): 609.

DOI: https://doi.org/10.1182/blood-2018-99-111614

Published: 2018

Journal Articles

Prediction of Leukemia-Free Survival Following Haploidentical Stem Cell Transplantation in Acute Myeloid Leukemia: A Study from the Acute Leukemia Working Party of the EBMT

Roni Shouval, MD PhD, Joshua A Fein, Myriam Labopin, MD, Fabio Ciceri, MD, Emanuele Angelucci, MD, Didier Blaise, Johanna Tischer, William Arcese, Koc Yener, MD, Benedetto Bruno, José Luís Díez Martín, MD, Stella Santarone, MD, Simona Sica, MD, Mohamad Mohty, MD PhD, Arnon Nagler, MD

Blood (2018) 132 (Supplement 1): 485.

DOI: https://doi.org/10.1182/blood-2018-99-111822

Published: 2018

Journal Articles

Comorbidity-Driven Risk across Preparative Regimens for Allogeneic Hematopoietic Stem Cell Transplantation

Joshua Fein, Noga Shem-Tov, MD, Ronit Yerushalmi, MD, Ivetta Danylesko, Nadav Furie, MD, Arie Apel, MD, Avichai Shimoni, MD, Arnon Nagler, MD, Roni Shouval

Blood (2017) 130 (Supplement 1): 1933.

DOI: https://doi.org/10.1182/blood.V130.Suppl_1.1933.1933

Published: 2017

NARROW

Early intestinal microbial features are associated with CD4 T-cell recovery after allogeneic hematopoietic transplant

TP53 and CD19-Directed Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in Large B-Cell Lymphoma

Five-Year Experience Using Bridging Radiotherapy Prior to Chimeric Antigen Receptor (CAR) T-Cell Therapies for B-Cell Malignancies at Memorial Sloan Kettering Cancer Center

KIR-HLA Interactions Lack Clinical Utility in Matched Unrelated Donor Transplantation for AML: An Analysis of the CIBMTR and DRST Registries

Lesion Characteristics and Patterns of Failure in Diffuse Large B Cell Lymphoma Patients Treated with Bridging Radiotherapy Prior to Chimeric Antigen Receptor T Cell Therapy

Novel Agents May be Preferable to Chemotherapy for Large B-Cell Lymphoma Progressing after CD19-CAR-T: A Multicenter Observational Study

Encouraging Survival and High Rates of Toxicity: Allogeneic Hematopoietic Cell Transplantation after Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy in Aggressive Lymphoma Patients

Primum non nocere: allo-HSCT for AML in CR1

Personalized Risk-Profiling for Acute Leukemia Patients Undergoing Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation: A Study on Behalf of the Acute Leukemia Working Party of the EBMT

The Disease-Risk Stratification Scheme (DRSS), a Contemporary Risk-Stratification System for Allogeneic Stem Cell Transplantation

Easix and Modified-Easix Are Early Predictors of Severe Cytokine Release Syndrome and Neurotoxicity in Patients Treated with Chimeric Antigen Receptor T Cells

Comparing Gradings of Immune Effector Cells Toxicities: Application of Astct Consensus Grading System and Implications for Clinical Management

Early Organ Toxicity Following Allogeneic Hematopoietic Stem Cell Transplantation Differs By Conditioning Regimen

Lactate Dehydrogenase Is a Key Prognostic Factor in Acute Myeloid Leukemia and Lymphoma Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Oral Mucositis Is Associated with Distinctive Patterns of Oral Microbiota Injury in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Comorbidity-Associated Risk of Overall Mortality Following Hematopoietic Stem-Cell Transplantation Is Regimen-Dependent: A Study from the Acute Leukemia Working Party of the EBMT

Repeated Courses of Orally Administered Fecal Microbiota Transplantation for the Treatment of Steroid Resistant and Steroid Dependent Intestinal Acute Graft Vs. Host Disease: A Pilot Study (NCT 03214289)

FLT3 and NPM1 Are Powerful Determinants of Outcome in Acute Myeloid Leukemia Patients Treated with Autologous Stem Cell Transplantation: An Analysis By the Acute Leukemia Working Party of the EBMT

Prediction of Leukemia-Free Survival Following Haploidentical Stem Cell Transplantation in Acute Myeloid Leukemia: A Study from the Acute Leukemia Working Party of the EBMT

Comorbidity-Driven Risk across Preparative Regimens for Allogeneic Hematopoietic Stem Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only